In an effort to identify novel molecular warheads able to inhibit Leishmania mexicana cysteine protease CPB2.8ÎCTE, fused benzo[b]thiophenes and β,βʹ-triketones emerged as covalent inhibitors binding the active site cysteine residue. Enzymatic screening showed a moderate-to-excellent activity (12%â90% inhibition of the target enzyme at 20 μm). The most promising compounds were selected for further profiling including in vitro cell-based assays and docking studies. Computational data suggest that benzo[b]thiophenes act immediately as non-covalent inhibitors and then as irreversible covalent inhibitors, whereas a reversible covalent mechanism emerged for the 1,3,3ʹ-triketones with a Y-topology. Based on the predicted physicochemical and ADMEâTox properties, compound 2b has been identified as a new drug-like, non-mutagen, non-carcinogen, and non-neurotoxic lead candidate.
Ensemble-based ADME-Tox profiling and virtual screening for the discovery of new inhibitors of the Leishmania mexicana cysteine protease CPB2.8ΔCTE
Rescifina, Antonio
;Grassi, Giovanni
2018-01-01
Abstract
In an effort to identify novel molecular warheads able to inhibit Leishmania mexicana cysteine protease CPB2.8ÎCTE, fused benzo[b]thiophenes and β,βʹ-triketones emerged as covalent inhibitors binding the active site cysteine residue. Enzymatic screening showed a moderate-to-excellent activity (12%â90% inhibition of the target enzyme at 20 μm). The most promising compounds were selected for further profiling including in vitro cell-based assays and docking studies. Computational data suggest that benzo[b]thiophenes act immediately as non-covalent inhibitors and then as irreversible covalent inhibitors, whereas a reversible covalent mechanism emerged for the 1,3,3ʹ-triketones with a Y-topology. Based on the predicted physicochemical and ADMEâTox properties, compound 2b has been identified as a new drug-like, non-mutagen, non-carcinogen, and non-neurotoxic lead candidate.File | Dimensione | Formato | |
---|---|---|---|
Ensemble-based ADME-Tox profiling.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Dimensione
720.96 kB
Formato
Adobe PDF
|
720.96 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.